DIABETIC PTS RECIPIENTS OF RENAL ALLOGRAFTS USING THE EDMONTON PROTOCOL IMMUNO

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是确定埃德蒙顿胰岛移植方案(他克莫司、西罗莫司和少量或不使用强的松)是否会改善既往进行过肾脏移植的1型糖尿病患者的胰岛细胞移植。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine if the Edmonton islet transplant protocol (tacrolimus, sirolimus and little or no prednisone) will improve islet cell transplantation in Type 1 diabetic patients with a previous kidney transplant.